APA (7th ed.) Citation

Tarragó, D., González, I., & González-Escribano, M. F. (2022). HLA-E restricted cytomegalovirus UL40 peptide polymorphism may represent a risk factor following congenital infection. BMC Genomics, 23(1), 1. https://doi.org/10.1186/s12864-022-08689-0

Chicago Style (17th ed.) Citation

Tarragó, David, Irene González, and Maria Francisca González-Escribano. "HLA-E Restricted Cytomegalovirus UL40 Peptide Polymorphism May Represent a Risk Factor Following Congenital Infection." BMC Genomics 23, no. 1 (2022): 1. https://doi.org/10.1186/s12864-022-08689-0.

MLA (9th ed.) Citation

Tarragó, David, et al. "HLA-E Restricted Cytomegalovirus UL40 Peptide Polymorphism May Represent a Risk Factor Following Congenital Infection." BMC Genomics, vol. 23, no. 1, 2022, p. 1, https://doi.org/10.1186/s12864-022-08689-0.